Answers are grounded in this paper and cite their sources.
PRCIS: Despite both CW-TSCPC and MP-TSCPC being effective in reducing IOP, with low rates of complications, MP-TSCPC appears to achieve higher success rates with less significant visual acuity loss compared with CW-TSCPC. PURPOSE: To compare the efficacy and safety of continuous wave transscleral cyclophotocoagulation (CW-TSCPC) using the slow-coagulation technique versus micropulse (MP) TSCPC in patients with glaucoma and good visual acuity. PATIENTS AND METHODS: Retrospective multicenter study including patients with logMAR visual acuity (VA) of <0.5 and at least 6 months of follow-up. Surgical success was defined as IOP ≤18 mm Hg and at least a 30% reduction from baseline IOP with or without glaucoma medication, without loss of >2 lines of vision. For criterion A, patients who required a new CPC session during follow-up were considered a failure. For criterion B, the additional need for CPC was not considered a failure. RESULTS: We included a total of 200 eyes from 200 glaucoma patients (110 eyes in the CW-TSCPC and 90 in the MP-TSCPC groups). There was a significant reduction in IOP levels and the number of medications after CPC in both groups ( P <0.001). Considering criterion A, success rates at 12 months were 61% and 76% in the CW-TSCPC and MP-TSCPC groups, respectively ( P =0.087). Considering criterion B, success rates were 75% and 87% in the CW-TSCPC and MP-TSCPC groups, respectively ( P =0.289). Significant VA loss was observed in 20% of the eyes in the CW-TSCPC group and 10% of the eyes in the MP-TSCPC group ( P =0.016). CONCLUSION: Both CW-TSCPC and MP-TSCPC are safe and effective in reducing IOP, with low rates of complications or serious adverse events.
No takes yet. Share an insight, caveat, or question.
Chaves et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: